| Precipio is a cancer diagnostics company providing diagnostic products and services to the oncology market. Co. has built and continue to develop a platform designed to eradicate the problem of misdiagnosis. Co. focuses on development of various technologies, among them IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). Co.'s liquid biopsy technology, ICP, enables detection of abnormalities in blood samples down to as low as 0.01%. We show 16 historical shares outstanding datapoints in our PRPO shares outstanding history coverage, used to compute PRPO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PRPO market cap history over the course of time is important for investors
interested in comparing PRPO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PRPO versus a peer is one thing; comparing
PRPO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PRPO can fluctuate over the course of history.
With this page we aim to empower investors researching PRPO by allowing them to research the PRPO market cap history.